A universal assay for detection of oncogenic fusion transcripts by oligo microarray analysis

Area of Science:

• Oncology
• Molecular Biology
• Genomics

Background:

• Detecting neoplasia-specific fusion genes is crucial for accurate cancer diagnosis and personalized treatment.
• Current methodologies for fusion gene detection have limitations.
• Fusion genes play a significant role in cancer development and progression.

Purpose of the Study:

• To develop a novel oligonucleotide microarray strategy for comprehensive screening of oncogenic fusion transcripts.
• To combine chimeric transcript junction detection with exon-wise measurements of fusion partners.
• To provide a single-experiment solution for detecting known fusion genes.

Main Methods:

• Designed a DNA microarray with 68,861 oligonucleotide probes.
• Included probes for all combinations of chimeric exon-exon junctions from 275 fusion gene pairs.
• Incorporated probes for individual exons of fusion partners.

Main Results:

• Successfully demonstrated proof of principle by detecting known fusion genes.
• Detected fusions such as TCF3:PBX1, ETV6:RUNX1, and TMPRSS2:ERG.
• Validated the approach using positive controls from leukemia cell lines and prostate cancer biopsies.

Conclusions:

• The novel microarray strategy offers a powerful new tool for fusion gene detection.
• This method can complement existing diagnostic and research tools for neoplastic diseases.
• It holds promise for improving the diagnosis and understanding of cancers driven by fusion genes.